Fortis Healthcare to Raise Rs 1,500 Crore Through NCDs
Written By : Meghna A Singhania
Published On 2024-10-12 09:00 GMT | Update On 2024-10-13 04:29 GMT
Advertisement
New Delhi: Fortis Healthcare Ltd recently announced that its board has approved raising up to Rs 1,500 crore through the issuance of non-convertible debentures via private placement.
The company's board of directors at its meeting held on October 9, 2024, considered and approved issue of non-convertible debentures (NCDs) on a private placement basis to eligible investors, according to a regulatory filing.
In the filing, the healthcare company said that the eligible investors include but are not limited to identified anchor investors DBS Bank Ltd (DBS), The Hongkong and Shanghai Banking Corporation Ltd (HSBC), Citicorp Investment Bank (Singapore) Ltd., Mizuho Bank, Singapore and other foreign portfolio investors qualified during the bidding process.
The sum is planned to be raised through three series with DBS Bank Ltd as anchor investor for Series 1 for up to Rs 500 crore; HSBC through its GIFT FPI as anchor investor for Series 2 of up to Rs 500 crore; and Citicorp Investment Bank (Singapore) Ltd, Mizuho Bank, Singapore as anchor investors of Series 3 of Rs 500 crore.
The NCDs will have a tenure of 5 years from the date of allotment and are proposed to be listed on BSE, the company said.
Shares of Fortis Healthcare settled 1.73 per cent higher at Rs 607.40 per piece on the BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.